Koers National Graphite Corp. Other OTC
Aandelen
NGRC
US6362682030
Biotechnologie & Medisch Onderzoek
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 7,61 mln. 7,12 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | - 0 | Nettowinst (verlies) 2015 | -1 mln. -935K | EV/omzet 2014 | - |
Nettoschuld 2014 | 23,32K 21,81K | Nettoschuld 2015 | 2,1 mln. 1,96 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-1,48
x | K/w-verhouding 2015 |
-3,21
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 63,71% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Chui
CEO | Chief Executive Officer | - | - |
Joe Wan
DFI | Director of Finance/CFO | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Chui
CEO | Chief Executive Officer | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |